Comparison Actuate Therapeutics (ACTU) with Competitors
Actuate Therapeutics (ACTU) industry is Biotechnology.
Free Cash Flow Yield
ACTU-39.18%
Industry-1.94%
Upside-37.24%
P/E
ACTU-2.21
Industry-18.88
Upside+1667.23%
P/B
ACTU12.77
Industry4.70
Upside+171.85%